Gilligan Michael, Lesnick Connie E, Guo Yong, Bradshaw Michael J, Ladha Shafeeq S, Nowak Mihaela, Shah Maulik P, Wittenborn John R, Basal Eati, Hinson Shannon, Yang Binxia, Dubey Divyanshu, Mills John R, Pittock Sean J, Zekeridou Anastasia, McKeon Andrew
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, University College Dublin, St Vincent's Hospital Elm Park, Dublin, Ireland.
Ann Neurol. 2024 Jul;96(1):21-33. doi: 10.1002/ana.26943. Epub 2024 Apr 18.
To report an autoimmune paraneoplastic encephalitis characterized by immunoglobulin G (IgG) antibody targeting synaptic protein calmodulin kinase-like vesicle-associated (CAMKV).
Serum and cerebrospinal fluid (CSF) samples harboring unclassified antibodies on murine brain-based indirect immunofluorescence assay (IFA) were screened by human protein microarray. In 5 patients with identical cerebral IFA staining, CAMKV was identified as top-ranking candidate antigen. Western blots, confocal microscopy, immune-absorption, and mass spectrometry were performed to substantiate CAMKV specificity. Recombinant CAMKV-specific assays (cell-based [fixed and live] and Western blot) provided additional confirmation.
Of 5 CAMKV-IgG positive patients, 3 were women (median symptom-onset age was 59 years; range, 53-74). Encephalitis-onset was subacute (4) or acute (1) and manifested with: altered mental status (all), seizures (4), hyperkinetic movements (4), psychiatric features (3), memory loss (2), and insomnia (2). Paraclinical testing revealed CSF lymphocytic pleocytosis (all 4 tested), electrographic seizures (3 of 4 tested), and striking MRI abnormalities in all (mesial temporal lobe T2 hyperintensities [all patients], caudate head T2 hyperintensities [3], and cortical diffusion weighted hyperintensities [2]). None had post-gadolinium enhancement. Cancers were uterine adenocarcinoma (3 patients: poorly differentiated or neuroendocrine-differentiated in 2, both demonstrated CAMKV immunoreactivity), bladder urothelial carcinoma (1), and non-Hodgkin lymphoma (1). Two patients developed encephalitis following immune checkpoint inhibitor cancer therapy (atezolizumab [1], pembrolizumab [1]). All treated patients (4) demonstrated an initial response to immunotherapy (corticosteroids [4], IVIG [2]), though 3 died from cancer.
CAMKV-IgG is a biomarker of immunotherapy-responsive paraneoplastic encephalitis with temporal and extratemporal features and uterine cancer as a prominent oncologic association. ANN NEUROL 2024;96:21-33.
报告一种自身免疫性副肿瘤性脑炎,其特征为免疫球蛋白G(IgG)抗体靶向突触蛋白钙调蛋白激酶样囊泡相关蛋白(CAMKV)。
通过人蛋白质微阵列筛选在基于鼠脑的间接免疫荧光试验(IFA)中含有未分类抗体的血清和脑脊液(CSF)样本。在5例具有相同脑IFA染色的患者中,CAMKV被确定为排名第一的候选抗原。进行了蛋白质印迹、共聚焦显微镜检查、免疫吸附和质谱分析以证实CAMKV的特异性。重组CAMKV特异性检测(基于细胞的[固定和活细胞]和蛋白质印迹)提供了额外的确认。
5例CAMKV-IgG阳性患者中,3例为女性(症状发作的中位年龄为59岁;范围为53 - 74岁)。脑炎起病为亚急性(4例)或急性(1例),表现为:精神状态改变(全部)、癫痫发作(4例)、运动过多(4例)、精神症状(3例)、记忆力减退(2例)和失眠(2例)。副临床检查显示脑脊液淋巴细胞增多(所有4例检测)、脑电图癫痫发作(4例检测中的3例)以及所有患者均有明显的MRI异常(内侧颞叶T2高信号[所有患者]、尾状核头部T2高信号[3例]和皮质扩散加权高信号[2例])。均无钆增强。癌症分别为子宫腺癌(3例患者:2例为低分化或神经内分泌分化,两者均显示CAMKV免疫反应性)、膀胱尿路上皮癌(1例)和非霍奇金淋巴瘤(1例)。2例患者在免疫检查点抑制剂癌症治疗后发生脑炎(阿特珠单抗[1例]、帕博利珠单抗[1例])。所有接受治疗的患者(4例)对免疫治疗(皮质类固醇[4例]、静脉注射免疫球蛋白[2例])均有初始反应,尽管3例死于癌症。
CAMKV-IgG是一种对免疫治疗有反应的副肿瘤性脑炎的生物标志物,具有颞叶和颞外特征,且子宫癌是主要的肿瘤学关联。《神经病学纪事》2024年;96:21 - 33。